Evidence map›Paper›PMID 40813815›Full record

ArticleInternational journal of legal medicine2025

Effect of the luminol test on blood mRNA detection: A pilot study.

Seiji Kubo, Fumitaka Nakano, Jin Tanaka, Hideki Niimi

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of legal medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Seiji Kubo *Department of Clinical Laboratory and Molecular Pathology, Faculty of Medicine, Academic Assembly, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan. kubo.s88@gmail.com.ORCID http://orcid.org/0000-0001-8401-7499
Fumitaka Nakano *Forensic Science Laboratory, Ishikawa Prefectural Police Headquarters, 1-1 Kuratsuki, Kanazawa, 920-8553, Japan.
Jin TanakaForensic Science Laboratory, Ishikawa Prefectural Police Headquarters, 1-1 Kuratsuki, Kanazawa, 920-8553, Japan.
Hideki NiimiDepartment of Clinical Laboratory and Molecular Pathology, Faculty of Medicine, Academic Assembly, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan. hiniimi@med.u-toyama.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Body fluid samples provide crucial evidence in forensic investigations. Analyzing them typically involves two types of tests: presumptive tests for preliminary screening and confirmatory tests for definitive identification. For example, the luminol test is a widely used presumptive test for detecting latent bloodstains at crime scenes. Upon reacting with blood, luminol produces luminescence, making invisible bloodstains detectable and aiding in blood sample collection. By contrast, messenger RNA (mRNA) analysis is used as a confirmatory test. Because these tests serve distinct purposes, forensic samples screened using presumptive tests may still be subjected to mRNA-based body fluid identification. Nevertheless, the effects of presumptive tests on subsequent mRNA analyses remain unclear. In this study, we assessed the effect of the luminol test on the detection of blood mRNA marker hemoglobin β (HBB). We found that although the luminol test resulted in HBB mRNA degradation, the RNA marker remained relatively stable in bloodstains dried after luminol testing. Our findings provide insights into the stability of HBB mRNA following luminol application.

Indexed as

Blood StainsLuminescent AgentsLuminolRNA, MessengerForensic SciencesHemoglobinsHumansPilot ProjectsReproducibility of ResultsRNA Stabilityhemoglobin BHemoglobinsLuminescent AgentsLuminolRNA, MessengerBloodHBBLuminolRNA

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.